Boston Scientific Corporation, a Marlborough, MA-based medical technology company, acquired Silk Road Medical, a medical device company.
The amount of the deal was not disclosed.
Boston Scientific expects to complete the transaction in the second half of 2024, subject to customary closing conditions.
Silk Road Medical is a medical device company that has developed a platform of products to prevent stroke in patients with carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR).
Boston Scientific develops medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, its portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions.
